Approved cancer drug may reduce kidney damage linked to nail-patella syndrome
Approved cancer drug may reduce kidney damage linked to nail-patella syndromeTreatment with bortezomib maintains the glomerular filtration barrier. Transmission electron micrographs demonstrate the dr
Updated on: November 01,2026
Approved cancer drug may reduce kidney damage linked to nail-patella syndrome
Approved cancer drug may reduce kidney damage linked to nail-patella syndromeTreatment with bortezomib maintains the glomerular filtration barrier. Transmission electron micrographs demonstrate the dr
Updated on:November 01,2026
